Walmart says baby formula availability improving in its stores [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
The shortage, initially spurred by pandemic-induced supply chain issues, was exacerbated in February when Abbott Laboratories, the biggest U.S. supplier of baby formula, recalled some products and closed a manufacturing plant on reports of bacterial infections. In response to the shortage, U.S. health regulators have since relaxed import policies and shipped in millions of cans of emergency supplies from companies such as Nestle SA and Reckitt Benckiser. Abbott in early July resumed partial production of certain specialty and metabolic formulas at its Sturgis facility as well as imported baby formula products from its international plants to boost supplies. Advertisement Walmart Chief Financial Officer John David Rainey said on an earnings call on Tuesday that the shortage of baby formula products the company experienced in a “big way” in the second quarter was improving. The retail bellwether also said it now expects a smaller drop in its annual profit forecast as discount
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Point of Care Diagnostics Analysis 2024: A $43.1 Billion Market in 2028, Driven by Rising Utilization of Novel Immunoassays Techniques and Increasing Usage of Home-Based Glucose Monitoring [Yahoo! Finance]Yahoo! Finance
- Inside The Collapse Of A Former Billionaire's Foundation For Low-Income Students [Forbes]Forbes
- After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1? [Forbes]Forbes
- Global BNP (Brain Natriuretic Peptide) and NT-proBNP (N-Terminal pro-Brain Natriuretic Peptide) Research 2023-2029: Cardiology's Biomarker Cornerstone, Personalized Medicine Takes Center Stage [Yahoo! Finance]Yahoo! Finance
- Core Clinical Molecular Diagnostics Market to Reach $11.9 Billion, Globally, by 2032 at 9.5% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/24/24 - In-Line
ABT
Sec Filings
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website